$SMG

Why is Scotts Miracle-Gro stock climbing today? By Investing.com

Scotts Miracle-Gro shares rose 1.4% pre-open after the company reported fiscal Q3 EPS of $2.82 versus $2.48 consensus, with revenue of $1.17B in line. It updated FY2026 EPS guidance to $4.30 to $4.45 and declared a $0.66 quarterly dividend payable Sept. 4. The report was the first under new CEO Nate Baxter.

Original reporting
Published Jul 29, 2026, 12:17 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 12:46 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$SMG
Bullish
high confidence
Mentioned
$SMG
Relevance
8/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$SMGBullishMed
01

Why it matters

The combination of an EPS beat, unchanged in-line revenue, and refreshed FY2026 EPS guidance range is the core driver for repricing expectations, with the dividend adding support for shareholder-return-focused flows.

02

Market read

Company-specific earnings and guidance details explain the pre-open rally and set expectations for FY2026 profitability and capital returns.

03

What to watch

The article mentions a Form 4 insider filing and CEO transition, but does not quantify insider trade direction or provide operational details that would confirm the durability of the turnaround.

Relevance 8/10Novelty 7/10Timing: pre-open trading reaction to the fiscal Q3 earnings and FY2026 guidance update

Background

SMG’s fiscal Q3 report is the first quarterly report under new CEO Nate Baxter after Jim Hagedorn’s late-June departure, and the board approved a quarterly cash dividend the day prior.

Company-level read

Ticker impact

$SMGBullishHigh confidence
Context

Scotts Miracle-Gro reported fiscal Q3 EPS of $2.82 vs $2.48 consensus and raised FY2026 EPS guidance to $4.30-$4.45.

Expected impact

Bullish bias for the next session as traders reprice FY2026 earnings power and capital-return expectations.

Evidence & confidence

The article cites specific EPS beat, in-line revenue, updated full-year guidance range, and a board-approved $0.66 quarterly dividend payable Sept. 4, all of which are direct valuation catalysts.

Market effects

Signals continued demand and margin resilience in consumer discretionary home-improvement/gardening inputs, potentially supporting sentiment for related retail and ag-input supply chains.

Primarily US-focused equity sentiment; no direct regional spillover beyond broad market tone.

Limited global read-through; commodity-input inflation (urea) is flagged as a watch item for fiscal 2027, which can matter for global fertilizer-linked costs.

Counterpoint

The guidance range only modestly straddles consensus and could still be vulnerable if commodity-input inflation (urea and other inputs) accelerates into fiscal 2027.

Key entities

  • Scotts Miracle-Gro

    Reported fiscal Q3 EPS of $2.82, issued FY2026 EPS guidance of $4.30-$4.45, and announced a $0.66 quarterly dividend payable Sept. 4, 2026.

  • Nate Baxter

    New CEO whose first quarterly report coincides with the earnings beat and guidance update.

Related articles

$SMGMed

Why is Scotts Miracle-Gro stock climbing today?

Scotts Miracle-Gro (SMG) shares rose 1.8% pre-open after the company held Investor Day 2026 and set mid-range targets for FY2027-2029, including 2% to 4% average annual net sales growth, adjusted EPS growth of 5% to 8%, and free cash flow above $275 million. Stifel raised its FY2026 EPS estimate to $4.44 and lifted its price target to $76.

$SMGMed

The Scotts Miracle-Gro Company Q3 2026 Earnings Call Summary

Strategic Shift and Operational Progress Management is executing a fundamental shift toward 'SMG 2.0,' prioritizing quality earnings and margin expansion over aggressive volume growth to ensure sustainable long-term value. The company deliberately exited approximately $100 million in low-margin commodity mulch and soil sales to reallocate resources toward high-margin branded products.

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

$JOBYMedAI 8/10

Joby Aviation Q2 Earnings Call Highlights

Joby Aviation (NYSE:JOBY) raised full-year revenue guidance to $115 million to $125 million from $105 million to $115 million. Q2 cash use was about $202 million and GAAP net loss was $245 million, including a $108 million non-cash warrant and earn-out fair value change. For 2H 2026, it expects $385 million to $415 million cash use. The company said aircraft availability is a key constraint on Blade routes and outlined manufacturing, infrastructure, and JV plans with Toyota.

$JHXMedAI 8/10

James Hardie Industries Q1 Earnings Call Highlights

James Hardie (NYSE:JHX) said about one-third of fiber-cement growth came from strategic initiatives, one-third from prior-year destocking comparisons, and the rest from price and mix. June sell-through rose 19%. Deck, Rail & Accessories sales fell 5% to $305.1M with 27.1% Adjusted EBITDA margin. Q2 net sales forecast $1.485B-$1.575B and FY2027 outlook raised; FCF Q1 was $254M and it redeemed $400M notes.